FDA blocks much-anticipated BioMarin hemophilia gene therapy

FDA blocks much-anticipated BioMarin hemophilia gene therapy


Health
Aug 19





File Photo by REUTERS/Jason Reed




FDA blocks much-anticipated BioMarin hemophilia gene therapy